|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99.06 CHF | +0.16% |
|
+2.03% | +16.72% |
| Jul. 15 | Brace for a flurry of speeches from Fed officials |  |
| Jul. 15 | European companies cut jobs as economy sputters | RE |
FRANKFURT, Jan 31 (Reuters) - Switzerland's Novartis on Wednesday updated its mid-term guidance, saying it expected sales to grow 5% per year until 2028, when adjusting for currency swings.
The core operating income margin would expand to about 40% by 2027, it added. (Reporting by Ludwig Burger, Editing by Rachel More)
| 1st Jan change | Capi. | |
|---|---|---|
| +16.72% | 225B | |
| +55.35% | 848B | |
| +31.64% | 627B | |
| -0.10% | 363B | |
| +15.47% | 318B | |
| +13.10% | 299B | |
| +15.51% | 243B | |
| +16.54% | 179B | |
| +4.31% | 167B | |
| +2.52% | 125B |
NOVARTIS AG 
